Expression defect of the rare variant/Brugada mutation R1512W depends upon the SCN5A splice variant background and can be rescued by mexiletine and the common polymorphism H558R

References

• Bennett PB, Yazawa K, Makita N, et al. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376(6542):683–685.
   PubMed Web of Science ®Google Scholar
• Makielski JC, Ye B, Valdivia CR, et al. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ Res. 2003;93(9):821–828.
   PubMed Web of Science ®Google Scholar
• Tan BH, Valdivia CR, Song C, et al. Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine. Am J Physiol Heart Circ Physiol. 2006;291(4):H1822–1828.
   PubMed Web of Science ®Google Scholar
• Tan BH, Valdivia CR, Rok BA, et al. Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants. Heart Rhythm. 2005;2(7):741–747.
   PubMed Web of Science ®Google Scholar
• Gellens ME, George AL Jr., Chen LQ, et al.: Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proceedings of the National Academy of Sciences of the United States of America 1992; 89:554–558.
   Google Scholar
• Remme CA. Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects. J Physiol. 2013;591(17):4099–4116.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Koopmann TT, Le Scouarnec S, et al. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest. 2008;118:2260–2268.
   PubMed Web of Science ®Google Scholar
• Makita N. Phenotypic overlap of cardiac sodium channelopathies: individual-specific or mutation-specific? Circ J. 2009;73(5):810–817.
   PubMed Web of Science ®Google Scholar
• Shinlapawittayatorn K, Dudash LA, Du XX, et al. A novel strategy using cardiac sodium channel polymorphic fragments to rescue trafficking-deficient SCN5 mutations. Circ Cardiovasc Genet. 2011;4(5):500–509.
   PubMedGoogle Scholar
• Deschenes I, Baroudi G, Berthet M, et al. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes.. Cardiovasc Res. 2000;46(1):55–65.
   PubMed Web of Science ®Google Scholar
• Zheng J, Zhou F, Su T, et al. The biophysical characterization of the first SCN5A mutation R1512W identified in Chinese sudden unexplained nocturnal death syndrome. Medicine (Baltimore). 2016;95(23):e3836.
   PubMed Web of Science ®Google Scholar
• Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–443.
   PubMed Web of Science ®Google Scholar
• Ackerman MJ, Splawski I, Makielski JC, et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm. 2004;1(5):600–607.
   PubMed Web of Science ®Google Scholar
• Shinlapawittayatorn K, Du XX, Liu H, et al. A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations. Heart Rhythm. 2011;8(3):455–462.
   PubMed Web of Science ®Google Scholar
• Ye B, Valdivia CR, Ackerman MJ, et al. A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation. Physiol Genomics. 2003;12(3):187–193.
   PubMed Web of Science ®Google Scholar
• Hu D, Viskin S, Oliva A, et al. Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction. Heart Rhythm. 2007;4(8):1072–1080.
   PubMed Web of Science ®Google Scholar
• Tester DJ, Valdivia C, Harris-Kerr C, et al. Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation. Heart Rhythm. 2010;7(7):912–919.
   PubMed Web of Science ®Google Scholar
• Hu RM, Tan BH, Tester DJ, et al. Arrhythmogenic biophysical phenotype for SCN5A mutation S1787N depends upon splice variant background and intracellular acidosis. PloS One. 2015;10(4):e0124921.
   PubMed Web of Science ®Google Scholar
• Hu RM, Tan BH, Orland KM, et al. Digenic inheritance novel mutations in SCN5a and SNTA1 increase late I(Na) contributing to LQT syndrome. Am J Physiol Heart Circ Physiol. 2013;304:H994–H1001.
   PubMed Web of Science ®Google Scholar
• Hu RM, Tester DJ, Li R, et al. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients. Channels (Austin, Tex). 2018;12(1):176–186.
   PubMed Web of Science ®Google Scholar
• Wang DW, Desai RR, Crotti L, et al. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation. 2007;115(3):368–376.
   PubMed Web of Science ®Google Scholar
• van Rijen HV, JM DB. Penetrance of monogenetic cardiac conduction diseases. A matter of conduction reserve? Cardiovasc Res. 2007;76:379–380.
   PubMed Web of Science ®Google Scholar
• Ruan Y, Denegri M, Liu N, et al. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3. Circ Res. 2010;106(8):1374–1383.
   PubMed Web of Science ®Google Scholar
• Valdivia CR, Ackerman MJ, Tester DJ, et al. A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine. Cardiovasc Res. 2002;55(2):279–289.
   PubMed Web of Science ®Google Scholar
• Moreau A, Keller DI, Huang H, et al. Mexiletine differentially restores the trafficking defects caused by two brugada syndrome mutations. Front Pharmacol. 2012;3:62.
   PubMed Web of Science ®Google Scholar
• Weiser T, Qu Y, Catterall WA, et al. Differential interaction of R-mexiletine with the local anestheti creceptor site on brain and heart sodium channel α-subunits. Mol Pharmacol. 1999;56(6):1238–1244.
   PubMed Web of Science ®Google Scholar
• Viswanathan PC, Benson DW, JR B. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest. 2003;111(3):341–346.
   PubMed Web of Science ®Google Scholar
• Gui J, Wang T, Trump D, et al. Mutation-specific effects of polymorphism H558R in SCN5A-related sick sinus syndrome. J Cardiovasc Electrophysiol. 2010;21(5):564–573.
   PubMed Web of Science ®Google Scholar
• Lizotte E, Junttila MJ, Dube MP, et al. Genetic modulation of brugada syndrome by a common polymorphism. J Cardiovasc Electrophysiol. 2009;20(10):1137–1141.
   PubMed Web of Science ®Google Scholar
• Marangoni S, Di Resta C, Rocchetti M, et al. A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization. Cardiovasc Res. 2011;91(4):606–616.
   PubMed Web of Science ®Google Scholar
• Matsumura H, Nakano Y, Ochi H, et al. Kihara Y: H558R, a common SCN5A polymorphism, modifies the clinical phenotype of Brugada syndrome by modulating DNA methylation of SCN5A promoters. J Biomed Sci. 2017;24(1):91.
   PubMed Web of Science ®Google Scholar
• Poelzing S, Forleo C, Samodell M, et al. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation. 2006;114:368–376.
   PubMed Web of Science ®Google Scholar
• Nunez L, Barana A, Amoros I, et al. p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient. Heart Rhythm. 2013;10(2):264–272.
   PubMed Web of Science ®Google Scholar